Negotiating Medical Insurance Drug Prices: The Role in Reducing Costs of Orphan Drugs for Rare Diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Negotiating Medical Insurance Drug Prices: The Role in Reducing Costs of Orphan Drugs for Rare Diseases

Published:2023-11-13 Issue: Volume:12 Page:8195
ISSN:2322-5939
Container-title:International Journal of Health Policy and Management
language:en
Short-container-title:Int J Health Policy Manag

Author:

Lu Jinmiao¹^ORCID,Ying Xiaohua²^ORCID,Li Zhiping¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy, National Children’s Medical Center, Children’s Hospital of Fudan University, Shanghai, China

2. NHC Key Laboratory of Health Technology Assessment, Department of Health Economics, School of Public Health, Fudan University, Shanghai, China

Publisher

Maad Rayan Publishing Company

Subject

Health Policy,Health Information Management,Leadership and Management,Management, Monitoring, Policy and Law,Health (social science)

Link

https://www.ijhpm.com/article_4525_0a129231d23db8f536b6938f347568df.pdf

Reference7 articles.

1. Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges

2. Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs

3. Why Does Price Control Policies Do Not Apply in the US Pharmaceutical Market, as Opposed to Many EU Markets?

4. Advance price or purchase commitments to create markets for treatments for diseases of poverty: lessons from three policies;Towse A;Bull World Health Organ,2005

5. World Health Organization (WHO). Designing Health Financing Systems to Reduce Catastrophic Health Expenditure. WHO; 2005.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP